Hypericin

• Description :

  Hypericin inhibits RANKL-mediated osteoclastogenesis via affecting ERK signalling in vitro and suppresses wear particle-induced osteolysis in vivo.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  504.45

• Molecular Formula :

  C30H16O8

• Notes :

  Research use only, not for human use.

• Receptor :

  Antibacterial|antiviral

• CAS Number :

  548-04-9